Ghrelin receptor agonists like anamorelin increase lean mass and stimulate appetite in cancer cachexia [72], but appetite stimulation may be counterproductive alongside GLP-1-mediated appetite suppression
Its important to note that this data is currently limited to psoriasis and psoriatic arthritis
Ideal candidates for GLP-1 injections are adults who are clinically obese (BMI of 30 or higher) or those who are overweight (BMI of 27 or higher) and have one or more weight-related health conditions, such as high blood pressure or diabetes
See How GLP-1 Works in the Body Understanding GLP-1 is easier when you can see it in action
Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment
Time-restricted feeding attenuated hypertension-induced cardiac remodeling by modulating autophagy levels in spontaneously hypertensive rats